Panic Disorder

... A Chance Find, and Voilà!

Goodbye, Hot Flashes.

Hello, Sleep.

- New York Times Article 6 of 7 in Health Skip to article NYTimes.com News Business Education Health International National New York/Region NYT Front Page Obituaries Science Sports Technology Washington Weather Features Arts Books Cartoons Crossword/Games Dining & Wine Fashion & Style Home & Garden Learning Network Magazine Movies Multimedia/Photos NYC Guide Theater Travel Week in Review Opinion Editorials/Op-Ed Readers' Opinions The Public Editor CLASSIFIEDS Autos Job Market Real Estate All Classifieds Go to a Section Log In - Register Now NYT Since 1981 NYT 1851-1980 Google/Web Multimedia NYC Guide Health Home Fitness & Nutrition Health Care Policy Mental Health & Behavior Columns Personal Health A Chance Find, and Voilà!

Goodbye, Hot Flashes.

Hello, Sleep.

Stuart Bradford Sign In to E-Mail This Printer-Friendly Reprints Save Article By JANE E.

BRODY Published: March 28, 2006 A widely used drug that has been mired in controversy for most of its decade-long life may now bring relief to postmenopausal women whose lives have been disrupted by unrelenting hot flashes.

The relief may be especially welcome to women who have had breast cancer and cannot take estrogen.

Skip to next paragraph Some Find Relief From the Heat by Changing Habits (March 28, 2006) The drug, best k...

... Lyrica Approved For The Treatment Of Generalized Anxiety Disorder (GAD) In Europe 28th March 2006 home xml feeds newsletter advertise accessibility contact Archive Search Medical Abbreviations Lyrica Approved For The Treatment Of Generalized Anxiety Disorder (GAD) In Europe This ArticleAlso Appears InPsychology/Psychiatry Main Category: Anxiety News Article Date: 28 Mar 2006 - 0:00am (UK)Pfizer Inc said today that the European Commission has approved Lyrica(R) (pregabalin) for the treatment of generalized anxiety disorder (GAD) in adults.

In the European Union, it is estimated that nearly 12 million patients suffer from GAD on a yearly basis yet only one-third of these patients are properly diagnosed and even fewer received effective treatment.

Lyrica's approval was based on five randomized double-blind clinical trials involving over 2,000 patients.

Data from a combination of five placebo-controlled studies demonstrate that Lyrica provides rapid and sustained efficacy for the treatment of GAD.

As early as the first week of treatment, Lyrica was shown to be significantly effective in providing relief of both emotional symptoms, such as depressive symptoms and panic, as well as physical symptoms, including headaches and muscle aches.

"GAD is much more than the normal anxiety people experience under times of stress.

It is a chronic, debilitating illness that can greatly d...

... WebWire® | Pfizer’s Lyrica Approved for the Treatment of Generalized Anxiety Disorder (GAD) in Europe Advanced Search March 27, 2006 Pfizer’s Lyrica Approved for the Treatment of Generalized Anxiety Disorder (GAD) in Europe Pfizer Inc3/27/2006 3:46:06 PM WebWire Related Industries Supplementary Medicine/Nutrition * An estimated 12 million patients in Europe suffer from generalized anxiety disorder, a common and chronic psychiatric disorder characterized by excessive worry and tension * UK Expert: "New treatment option to help alleviate a broad range of emotional and physical symptoms" NEW YORK, March 27 - Pfizer Inc said today that the European Commission has approved Lyrica® (pregabalin) for the treatment of generalized anxiety disorder (GAD) in adults.

In the European Union, it is estimated that nearly 12 million patients suffer from GAD on a yearly basis yet only one-third of these patients are properly diagnosed and even fewer received effective treatment.

Lyrica’s approval was based on five randomized double-blind clinical trials involving over 2,000 patients.

Data from a combination of five placebo-controlled studies demonstrate that Lyrica provides rapid and sustained efficacy for the treatment of GAD.

As early as the first week of treatment, Lyrica was shown to be significantly effective in providing relief of both emotional sym...